Endothelial Dysfunction Global Clinical Trials Review, H1, 2015

Endothelial Dysfunction Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2580CTIDB
  • |
  • Pages: 84
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Endothelial Dysfunction Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Endothelial Dysfunction Global Clinical Trials Review, H1, 2015" provides data on the Endothelial Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endothelial Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endothelial Dysfunction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Endothelial Dysfunction 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Endothelial Dysfunction 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Endothelial Dysfunction Therapeutics Clinical Trials 31

Prominent Drugs 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Novartis AG 34

Clinical Trial Overview of Novartis AG 34

GlaxoSmithKline plc 35

Clinical Trial Overview of GlaxoSmithKline plc 35

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

BioMarin Pharmaceutical Inc. 37

Clinical Trial Overview of BioMarin Pharmaceutical Inc. 37

Takeda Pharmaceutical Company Limited 38

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 38

Sanofi 39

Clinical Trial Overview of Sanofi 39

Nestle S.A. 40

Clinical Trial Overview of Nestle S.A. 40

Gilead Sciences, Inc. 41

Clinical Trial Overview of Gilead Sciences, Inc. 41

C. H. Boehringer Sohn AG & Co. KG 42

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 42

Clinical Trial Overview of Top Institutes / Government 43

National Defense Medical College 43

Clinical Trial Overview of National Defense Medical College 43

Mayo Clinic 44

Clinical Trial Overview of Mayo Clinic 44

Radboud University 45

Clinical Trial Overview of Radboud University 45

Boston University 46

Clinical Trial Overview of Boston University 46

Gulhane School of Medicine 47

Clinical Trial Overview of Gulhane School of Medicine 47

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 48

Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 48

Vanderbilt University 49

Clinical Trial Overview of Vanderbilt University 49

University of Dundee 50

Clinical Trial Overview of University of Dundee 50

Emory University 51

Clinical Trial Overview of Emory University 51

UMC Utrecht Holding BV 52

Clinical Trial Overview of UMC Utrecht Holding BV 52

Five Key Clinical Profiles 53

Appendix 82

Abbreviations 82

Definitions 82

Research Methodology 83

Secondary Research 83

About GlobalData 84

Contact Us 84

Disclaimer 84

Source 84

List of Figures

Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 83

List of Tables

Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region, 2015* 7

Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Endothelial Dysfunction Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Endothelial Dysfunction Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Endothelial Dysfunction Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 35

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2015* 37

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 38

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 39

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015* 40

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 41

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 42

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Defense Medical College, 2015* 43

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 44

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 45

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2015* 46

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gulhane School of Medicine, 2015* 47

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2015* 48

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 49

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2015* 50

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 51

Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015* 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Endothelial Dysfunction Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Endothelial Dysfunction, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162350
Site License
USD 5000 INR 324700
Corporate User License
USD 7500 INR 487050

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com